Drug
Meloxicam 7.5 mg
Meloxicam 7.5 mg is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
50%
Ph not_applicable
1
25%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
recruiting125%
completed375%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_4
Meloxicam in Mohs Micrographic Surgery
NCT07200544
completednot_applicable
Effectiveness of Premedication on the Success Rate of Inferior Alveolar Nerve Block
NCT05097768
completedphase_2
Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea
NCT02183025
completedphase_2
Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar
NCT02183051
Clinical Trials (4)
Showing 4 of 4 trials
NCT07200544Phase 4
Meloxicam in Mohs Micrographic Surgery
NCT05097768Not Applicable
Effectiveness of Premedication on the Success Rate of Inferior Alveolar Nerve Block
NCT02183025Phase 2
Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea
NCT02183051Phase 2
Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4